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Fibrodysplasia ossificans progressiva (FOP) is a rare disease in which heterotopic
ossification (HO) is formed in muscles, tendons and ligaments. Traumatic events,
including surgery, are discouraged as this is known to trigger a flare-up with risk
of subsequent HO. Anesthetic management for patients with FOP is challenging.
Cervical spine fusion, ankylosis of the temporomandibular joints, thoracic insufficiency
syndrome, restrictive chest wall disease, and sensitivity to oral trauma complicate
airway management and anesthesia and pose life-threatening risks. We report a
patient with FOP suffering from life-threatening antibiotic resistant bacterial infected
ulcers of the right lower leg and foot. The anesthetic, surgical and postoperative
challenges and considerations are discussed. In addition, the literature on limb
surgeries of FOP patients is systemically reviewed. The 44 year-old female patient was
scheduled for a through-knee amputation. Airway and pulmonary evaluation elicited
severe abnormalities, rendering standard general anesthesia a rather complication-prone
approach in this patient. Thus, regional anesthesia, supplemented with intravenous
analgosedation and N2 O-inhalation were performed in this case. The surgery itself was
securely planned to avoid any unnecessary tissue damage. Postoperatively the patient
was closely monitored for FOP activity by ultrasound and [18 F]PET/CT-scan. One year
after surgery, a non-significant amount of HO had formed at the operated site. The

Frontiers in Endocrinology | www.frontiersin.org

1

August 2020 | Volume 11 | Article 570

Botman et al.

Through-Knee Amputation in FOP

systematic review revealed seventeen articles in which thirty-two limb surgeries in FOP
patients were described. HO reoccurrence was described in 90% of the cases. Clinical
improvement due to improved mobility of the operated joint was noted in 16% of the
cases. It should be noted, though, that follow-up time was limited and no or inadequate
imaging modalities were used to follow-up in the majority of these cases. To conclude,
if medically urgent, limb surgery in FOP is possible even when general anesthesia is not
preferred. The procedure should be well-planned, alternative techniques or procedures
should be tested prior to surgery and special attention should be paid to the correct
positioning of the patient. According to the literature recurrent HO should be expected
after surgery of a limb, even though it was limited in the case described.
Keywords: fibrodysplasia ossificans progressiva (FOP), surgery, heterotopic ossification (HO), [18 F]NaF PET/CT,
ACVR1 gene mutation

INTRODUCTION

normal Tiffeneau index (94%). This suggests a severely restrictive
pulmonary function, compatible with marked chest wall rigidity
(9). In 2016 the patient recovered without sequelae from a
cerebrovascular accident (CVA), for which she is on chronic
anticoagulation therapy (thrombocyte aggregation inhibitor). In
addition, her fifth digit of the right foot was amputated in
2001 because of an incurable osteomyelitis. This procedure has
previously been described (10). The patient has been treated
in our center since 2016 for recurrent skin infections of the
right lower leg and foot as a result of progressive chronic
ulcers. A neuropathic pain syndrome, clinically confirmed by
the neurologist, was thought to be the cause of allodynia in
the right lower leg. Repeated pressure on the skin while sitting
in her wheelchair contributed to formation of these ulcers.
Initially, the ulcer at the foot led to recurrent skin and soft
tissue infections of the right lower leg, with good response to
antimicrobial treatment. Wound care led to improvement of
the ulcer, but edema complicated healing. Intensive wound care,
application of tailored wound dressing, and systemic treatment
with antimicrobial agents with high bio-availability, targeted at
cultured bacteria found in biopsies of the wound surface, resulted
only in temporary improvements of wound healing. Custommade shoes were manufactured to locally decrease pressure on
the (pre)ulcer sites. With especially the combination of rigidity
of the body and the wheelchair which can be adjusted into
different positions turned out to be challenging in the use of
these shoes. Initially it led to an improvement of the ulcers.
But, unfortunately, after years of treatment the ulcers and
infections progressed to chronic osteomyelitis with multidrug
resistant microorganisms (including Pseudomonas aeruginosa)
in visible and palpable bone in the wound surface (Figure 1).
We expected her to develop a life-threatening sepsis in the
near future. In a multidisciplinary FOP team, consisting of
an endocrinologist, infectious disease specialist, pulmonologist,
surgeon, anesthesiologists and rehabilitation specialist, the case
was thoroughly discussed. The team concluded that amputation
of the infected part of the lower leg was the only life-saving
option. The patient was well-informed about the risks of the
anesthesia, surgery and the risk of FOP activity after surgery and
consented for a surgical procedure.

Fibrodysplasia Ossificans Progressiva (FOP) is an extremely rare
disease with heterotopic ossification (HO) occurring in muscles,
tendons and ligaments (1–3). HO usually leads to immobility of
the affected joint, resulting in wheelchair-dependence at an early
age (4). A flare-up often precedes the formation of this ectopic
bone (1–4). A flare-up can occur spontaneously, but can also
be triggered by a trauma (2, 4). Because trauma causes flareups and therefore aggravates the disease, patients are instructed
to be careful (e.g., do not engage in contact sports), to refuse
intramuscular injections and to prevent any kind of surgery (5).
In some cases, though, surgery is inevitable when a medical
condition is life-threatening. Surgical procedures can be difficult
as extensive HO throughout the body has led to ankylosis of
joints and has changed the patient’s anatomy, making proper
positioning of the patient difficult (4). Also, the anesthetic
procedures are complex. The jaw of the patient is often ankylosed
and pulmonary function can be severely restricted. As a result,
standard anesthesia techniques can often not be applied to FOP
patients (4, 6, 7). We report a patient with FOP who underwent
a through-knee amputation due to a life-threatening antibiotics
resistant infection. The surgical, anesthetic and postoperative
considerations and challenges will be discussed. In addition,
a systematic review on surgical procedures of the limbs and
the course of the postoperative disease activity in FOP patients
undergoing limb surgery is described.

CASE REPORT
The patient, a 44 year old woman at the time of surgery, is
known with the classical mutation (p.Arg206His) of FOP. Due
to widespread HO throughout the body, she has been wheelchair
bound and ADL (activities of daily life) dependent for over
25 years. Her joints are almost completely ankylosed except
for ankles, toes, wrists and fingers i.e., cumulative analog joint
involvement scale (CAJIS) score of 24 out of 30 (8). A recent
pulmonary function tests showed a severely reduced Forced
Expiratory volume in one second (FEV1) (0.6L, 25% of predicted)
and forced vital capacity (FVC) (0.6L, 22% of predicted) with a
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FIGURE 1 | FOP patient with multiple incurable ulcers at the right lower extremity (A). Ulcer located at the right calcaneus. Despite Intensive wound care,
custom-made orthopedic shoes and targeted systemic and topical antimicrobial treatment, surgical intervention was unavoidable. Due to an ulcer on the calf (B) and
proximal from the knee, a through-knee amputation was thought to be most favorable for adequate healing and to minimize tissue damage.

Anesthetic Management

served as light anxiolytic and amnestic sedative, and to prevent
psychomimetic side effects of s-ketamine. S-ketamine served
as systemic analgesic without cardiovascular and respiratory
depression. The N2 O-inhalation induced additional analgesia,
supplementing the analgesic effects of the regional anesthesia.
Together, this ensured adequate analgesia and patient comfort
for the remainder of the surgery, with a spontaneously
breathing, responsive patient. Postoperatively, the patient did
not recall having experienced any pain during the procedure.
The nerve catheters were used postoperatively to administer
continuous bupivacaine 0.125% for pain control, enabling to
avoid the use of systemic opioids. The catheters were removed
8 days postoperatively when oral medication was sufficient to
control pain.

Anesthesiologists of our FOP expertise center in Amsterdam
managed the anesthetic care. General anesthesia was
intentionally avoided as airway management appeared rather
challenging in this patient with severely impaired mouth opening
(<2 mm). Moreover, mechanical ventilation was expected to
temporarily cause a decline in pulmonary function, potentially
leading to a ventilation-perfusion mismatch or barotrauma,
and rendering weaning from mechanical ventilation impossible.
Regional anesthesia was therefore selected as the preferred
technique. Two peripheral nerve block catheters were placed
at the femoral and sciatic nerve on the pre-operative day
(Figure 2A). Damage to surrounding tissues was not completely
avoidable, but kept to a minimum by using ultrasound guidance.
The femoral nerve was easily identified in the femoral triangle.
The identification of the sciatic nerve with ultrasound, however,
was challenging because of an altered anatomy caused by HO
(e.g., altered landmarks and aberrant course of the nerve).
Eventually the sciatic nerve was identified and approached
at the subgluteal level. To prevent inflammation at those
sites, 40 mg methylprednisolone was administered over the
two nerve block catheters. Pre-operatively, 12 ml ropivacaine
0.375% was injected in the catheters. The ropivacaine spread
around the nerves as confirmed by sonography. Nerve block
effectiveness was confirmed using cold discrimination tests
prior to commencement of surgery. Surgery was initiated
and anesthesia was judged adequate for the initial part of the
procedure. The patient remained conscious and responsive
throughout the procedure, but started to report some discomfort
once surgery reached deeper tissue planes. The regional
anesthesia was therefore supplemented by intravenous bolus
titration of midazolam and s-ketamine, and inhalation of a mix
of 50% N2 O and 50% O2 via face mask. Herein, midazolam
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Surgical Management
Due to therapy-resistant infected ulcers 10 cm below the knee
and more distally, it was decided to perform an amputation
through the knee after an extensive discussion with our team
and the patient. Thirty minutes prior to surgery, 30 mg of
prednisolone was administered intravenously to prevent flareups. The surgery was performed by a surgeon affiliated to the
FOP Expert Center of Amsterdam UMC. The positioning of
the patient was challenging, due to complete immobility of the
major joints (Figure 2B). Time was taken to carefully position
the patient and soft pads were used to minimize pressure on
the soft tissues. Once positioned, the patient was put in adjusted
supine position and the knee joint was marked. A tourniquet
was not used to avoid tissue compression that may induce a
flare-up. As post-operative soft tissue healing complications were
expected, the skin flap and gastrocnemius muscle transposition
were designed to opposite each other in order to minimize
the chance of deep infection and fistula formation. While most
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FIGURE 2 | Anesthetic and surgical management of a through-knee amputation in an FOP patient. (A) Two nerve block catheters, i.e., the femoral (F) and the sciatic
nerve block catheter (S), which were both already placed and tested at the preoperative day. The picture shows the antero-lateral aspect of the patient’s right leg. The
femoral nerve block catheter is positioned at the ventral aspect of the leg, whereas the sciatic nerve catheter is positioned at the lateral aspect of the leg. (B) The
patient was carefully positioned on the theater table to prevent any tissue damage that might cause FOP disease activity. The positioning was challenging due to
ankylosis in the hips and knees, resulting in the position shown in the picture. (C) Surgical procedure was performed carefully to minimize tissue damage that might
cause a flare-up. (D) The skin flap and gastrocnemius muscle transposition were designed to opposite each other to prevent overlapping scars and minimize the
chance of fistula formation due to expected wound healing issues. Lateral of the stump an area of necrosis developed, but healed with supportive care.

Postoperative Management

ligaments and the capsule of the knee joint were ossified, no
abnormalities were observed in the knee joint itself (Figure 2C).
As the patella was fused with the distal femur, it was left in situ
to minimize tissue damage. Furthermore, the popliteal artery
and nerve were difficult to identify initially, as the patient’s leg
was in a fixed position. This posed a potential risk in case of
laceration of the vessel, but could be avoided by diligence. The
gastrocnemius muscles were transposed forward and fixed near
the patella region to cover the bone, to provide a vascularized bed
and to protect underlying tissues in case of a future prosthesis
(Figure 2D). The anterior skin of the proximal lower leg was
fixed to the posterior skin at the level of the knee. Postoperatively,
extra padding was applied between the lower extremities, to avoid
pressure from the left knee on the wound of the stump. The
patient developed partial skin necrosis laterally of the stump
(Figure 2D), but healed with supportive care.
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The patient’s disease activity was closely monitored with
ultrasound imaging and [18 F]NaF PET/CT (sodium fluoride
positron emission tomography and computed tomography).
Ultrasound imaging was obtained daily to evaluate oedema at
the surgical site and at the site of the anesthetic catheters. From
day one until day fourteen, mild oedema was seen laterally
from the stump by ultrasound. This oedema, however, did not
progress over time. It was interpreted as a normal postoperative
tissue reaction. To evaluate osteoblastic activity, an [18 F]NaF
PET/CT-scan was obtained 14 days after surgery, showing only
a mild increased [18 F]NaF-uptake (Standardized uptake value
(SUVmax ): 6.4) at the base of the distal femur. Because the
postoperative [18 F]NaF uptake was only slightly elevated (11),
it was decided not to administer extra prednisolone. A followup [18 F]NaF PET/CT-scan was obtained 8 weeks after surgery,
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(including synonyms and closely related words) as index
terms or free-text words: “Myositis ossificans,” “Fibrodysplasia
ossificans,” “Surgery,” “Anesthesia.” The references of the
identified articles were searched for relevant publications.
Duplicate articles were excluded. Only English articles were
accepted. The full search strategies for all databases can be
found in the Supplementary Material. Two reviewers (EB and
ST) independently screened all potentially relevant titles and
abstracts for eligibility. If necessary, the full text article was
checked for the eligibility criteria. Differences in judgement
were resolved through consensus. Studies were included when
a surgical procedure of the limb and its outcome (either HOformation or clinical outcome) were described. Patients of all
ages were included, as well as all types of surgeries of the limb.
The literature search generated a total of 1,774 references: 692
in PubMed and 1,082 in Embase. After removing duplicates of
references that were selected from more than one database, 1,223
references remained. The flow chart of the search and selection
process is presented in Figure 4. Seventeen articles described
cases in which FOP patients underwent surgery for the upper
and/or the lower limbs. In these seventeen articles, thirty two
procedures were described in twenty patients. Ten procedures
involved the upper limbs (12–19), twenty-two the lower limbs
(Table 1) (12, 13, 19–28).

revealing minimal HO formation (4 cc) at the base of the femur
(Figure 3). Another follow-up scan obtained 12 months after
surgery, revealed no further progression of HO evaluated by
CT. Interestingly, the patient’s disease activity as evaluated by
[18 F]NaF-activity on PET, now showed an increased [18 F]NaFuptake at multiple sites of HO throughout the body, whereas in
the previous 4 years there has not been any [18 F]NaF activity
nor a volumetric increase of HO as evaluated by CT. The
quiescence of disease was in a period of progressive infectious
ulcers and under continuous antibiotic therapy before surgery.
After 14 days, the patient was transferred to a rehabilitation
center. Since the patient was unable to see the stump and still
feels the presence of her amputated lower leg, rehabilitation
was needed to make her aware of the new situation and to
find a new balance during transfers. The main goals of the
rehabilitation were therefore to relearn the patient to make
a standing transfer with help. The transfers were intensively
practiced with the patient and her mother, who is an important
informal care taker of the patient. Also, the electric wheelchair
was adjusted to her new situation. After 4 months, the patient
returned home. At the most recent follow-up, 14 months after the
surgery, the patient was doing well. Now, the patient is under the
care of the department of rehabilitation medicine at Amsterdam
UMC exploring the possibilities of a cosmetic prosthesis of the
lower limb.

Procedures on the Upper Extremities
SYSTEMATIC REVIEW

All ten surgeries performed on the upper limbs were done to
remove either an undiagnosed swelling or mature HO. The
reoccurrence of HO was described for eight of the ten procedures
(12–15, 18, 26) and the clinical outcome for nine cases (12, 14,
15, 18, 19, 26). Reoccurrence of HO was observed in all eight
procedures, however, in four of the nine procedures for which
the clinical outcome was described, a clinical improvement was
noted (12, 15, 19). Clinical improvement in one patient was
due to a better position of the joint (15), whereas three other
cases describe an improved movement in the joint after surgery
(12, 19). For these cases, though, the follow-up period was 5
to 6 months. The time for HO to redevelop after surgery was

Literature was systemically reviewed to identify cases in which
FOP patients underwent surgery of a limb and the effect of
the procedure on the disease activity. The literature search
was performed based on the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA)-statement
(www.prisma-statement.org).
To identify all relevant publications, we conducted systematic
searches in the bibliographic databases PubMed and Embase
from inception to May 2, 2019, in collaboration with a
medical information specialist. The following terms were used

FIGURE 3 | Axial Low dose CT-images at the level of the distal femur of a patient prior to and after a through-knee amputation of the right leg. (A) Eight months prior
to the surgery. (B) Twelve months after the surgical procedure. Minor HO formed (4cc) on the right side posterior to the lateral femoral condyle (red arrow). FOP,
fibrodysplasia ossificans progressiva; HO, heterotopic ossification; CT, computed tomography.
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FIGURE 4 | Flowchart of the study selection process.

surgical procedures were done because of compression of HO
on surrounding tissues, and resulted in less pain (21, 27). In
two cases mobility was not restored, but a better position of
the joint was achieved, increasing functionality (20, 26). In only
one patient there was an actual improvement of mobility of the
operated joint (13). The anesthetic management was mentioned,
but not discussed in detail, in three case reports. Surgery to
unlock the hip was performed under general anesthesia, whereas
surgery on the knee joint was done under a subarachnoid block.

only described in only one case, i.e., 3 months (15). In the
majority of the cases, the method to detect reoccurrence of HO
and its extensiveness was not described. In all reports, neither
the anesthetic management nor the selected operative method
were discussed.

Procedures on the Lower Extremities
Of the twenty-two described lower limb surgeries, performed in
sixteen patients, twenty procedures were performed to remove
HO and restore joint mobility (12, 13, 19–21, 23, 24, 26, 27). In
one case, however, surgery was needed for fracture management
(25), and in another case the operation was to close a chronic
ulcer with skin grafts (28). In all but three cases in which
HO reoccurrence was described (19/22), the removal of HO
was complicated by reoccurrence of HO at the operated site
(12, 13, 19, 20, 23–26, 28). Two of these three cases without
any HO recurrence involved more than just the skin, however,
adequate follow-up data on these cases are lacking (19). The
time before HO was noticed ranged from 4 weeks to 36 months
(13, 19, 20, 23, 24, 26). Despite reoccurrence, however, five of the
sixteen cases in which clinical outcome was described, a clinical
improvement after surgery was found (13, 19, 21, 26, 27). Two

Frontiers in Endocrinology | www.frontiersin.org

Perioperative Medication to Prevent HO
Medication was used prior, during or after the procedure in
15 of the 32 surgeries (12, 13, 19, 20, 23, 26). In twelve
of these cases bisphosphonates were used in attempt to halt
(re)mineralization (12, 19, 20, 23, 26). Bisphosphonates were
given as monotherapy (n = 8), or combined with non-steroidal
anti-inflammatory drugs (n = 2) or corticosteroids (n = 2).
The other treatments given were either NSAIDs combined with
one fraction of radiotherapy (n = 1), subsequent fractions
of radiotherapy (n = 1) or corticosteroids (n = 1) (12,
13, 19). For eleven of those fifteen procedures the effect of
the procedure on HO reoccurrence was described: ten were
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Benetos et al. (13)

Patient

1

Age
FOP(years) diagnosis
(Y/N/U)*

Body part

Reason surgery

HO
(re)occurrence
(Y/N/U)

(re)occurrence
HO noted
(months)

Duration
follow-up
(months)

Clinical
improvement
(Y/N/U)

Medication
used pre-,
peri- or postoperatively

14

Y

Shoulder

Unlock joint

Y

U

U

U

-

18

Y

Hip

Unlock Joint

Y1

7

12

Y, improved mobility

Indomethacin 25 mg/3 dd, RT:
7 Gy in 1 fraction

1

60

N

Corticosteroids 30 mg/kg,
Alendronate 10/mg/day
-

Colmenares-Bonilla et al. (20)

2

11

Y

Knee

Unlock joint

Y1

Connor et al. (14)

3

1

N

Shoulder

Remove swelling

Y

-

U

N

4

6

U

Shoulder

Unlock joint

Y

U

U

N

-

Corfield et al. (15)

5

24

Y

Wrist

Improve position

Y1

3

3

Y: functional position

-

Duan et al. (21)

6

17

Y

Hip

HO induced
claudication

U

U

24

Y: no claudication

-

Holmsen et al. (23)

7

20

Y

Hips

Unlock joint

Y1

2

24

N

EHDP 10 mg/kg/day

Jayasundara et al. (12)

8

47

Y

Shoulder

Unlock joint

Y2

U

U

Y: improved mobility

Bisphosphonates, indomethacin

52
Kartal et al. (24)

9

7
Smith et al. (19)

10
11

12

Hip

Unlock joint

Y2

U

U

N

Bisphosphonates, indomethacin

Hip

HO induced
pressure necrosis

U

-

U

N

RT: 26 Gy in 13 fractions

13

N

Hip

Unlock joint

Y

1.5

12

N

-

14

N

Hip

Unlock joint

Y

3

12

N

-

15

N

Hip

Unlock joint

Y

U

12

N

-

34

U

Calf

Unlock joint

N1

-

U

U

EHDP 20 mg/kg/day

Elbow

Unlock joint

U

-

U

Y: improved mobility

EHDP 20 mg/kg/day

Foot

Unlock joint

Y

3

3

U

17

16

Foot

Unlock joint

Y

U

U

U

18

Hip

Unlock joint

Y

U

U

U

23

Foot

Unlock joint

Y1

36

36

U

U

Hip

Unlock joint

Y1

7

7

N

EHDP 20 mg/kg/day

Hamstring

Unlock joint

Y

U

U

U

Prednisone 7.5 mg/day

17

U

U

18
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TABLE 1 | Articles describing HO reoccurrence and/or clinical outcome after surgery of a limb in an FOP patient.

EHDP 20 mg/kg/day

Biceps

Unlock joint

U

-

U

Y: improved mobility

EHDP 20 mg/kg/day

Hip

Unlock joint

N1

-

24

Y: improved mobility

EHDP 20 mg/kg/day

21

U

Hip1

Unlock joint

Y

2

5

N

EHDP 20 mg/kg/day

Kocyigit et al. (18)

14

15

N

Elbow

Unlock joint

Y

U

U

N

-

Matsuda et al. (28)

15

35

Y

Malleolus

Incurable ulcer

N

-

8

N

-

Nerubay et al. (25)

16

7

Y

Femur

Fracture

Y

U

12

N

-

Obamuyide et al. (16)

17

11

N

Axilla

Unlock joint

Y

U

U

N

-

Tiwari et al. (17)

18

2

N

Arm

Removal swelling

Y

U

U

N

-

Trigui et al. (26)

19

25

Y

Hip

Unlock joint

Y1

2

24

Y: functional position

Corticosteroids, bisphosphonates

Waller et al. (27)

20

23

Y

Hip

HO induced pain

U

-

U

Y: less discomfort

-

HO reoccurrence is stated as YES when the article has specifically mentioned the reoccurrence of HO, YES1 when confirmed by X-rays and YES2 when confirmed by CT. FOP diagnosis is states as UNKNOWN when the confirmation
of the diagnosis was not specifically mentioned in the article. FOP, fibrodysplasia ossificans progressiva; Y/N/U, Yes/no/unknown; HO, heterotopic ossification; RT, Radiotherapy; Gy, gray; EHDP, Ethylene Hydroxydiphosphonate.
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followed by HO reoccurrence. The one case in which there
was no reoccurrence, the duration of follow-up is unknown
(19). Outcomes in the group without treatment (n = 17)
were described for fifteen procedures: fourteen were followed
by HO. The one case without reoccurrence was a superficial
surgical procedure involving a skin graft for an ulcer on the
malleolus (28).

through-knee amputation was performed which is a procedure
with relatively limited trauma to muscles because the procedure
does not affect normal skeletal bone and it mainly involves the
origin and insertion of muscles and tendons. In addition, when
possible, ankylosed bone parts were left in situ to minimize tissue
damage. To limit the extent of HO formation after surgery, it
has been suggested to administer corticosteroids as a prophylaxis
for four consecutive days after surgery (5). Objective data on
the effectiveness of glucocorticoids in flare-ups are lacking. But
based on empirical data, it is believed that it reduces oedema and
may cause symptom relief (4). Glucocorticoids are currently the
only treatment available for FOP. Corticosteroids, however, also
interfere with wound healing. Therefore, in the current case, they
were only administered pre-operatively. Hopefully, an effective
treatment will be available to halt the formation of HO in the
near future. To date, four potential drugs are tested in a clinical
trial: Palovarotene, Garatosmab, Rapamycin and Saracatinib (32–
35). Once found effective in preventing HO formation, surgical
treatment might be an option to unlock joints or to safely operate
an FOP patient for any other condition under an umbrella of
one (or a combination) of these drugs. Besides the impact of the
surgical procedure and the attempt to suppress FOP activity with
glucocorticoids, the anesthetic management is another major
concern and challenge in FOP patients. Regional anesthesia
techniques (peripheral nerve blocks) involve punctures causing
tissue trauma with increased risk of flare-ups, and these are
therefore considered contraindicated. Likewise, neuraxial (spinal
or epidural) anesthesia is not recommended for the following
reasons. First of all, the spine is often involved in the disease
and thus inapproachable for puncture. Secondly, the puncture
itself might trigger HO formation, which could compress
the spinal cord (5). Therefore, general anesthesia is generally
recommended for FOP patients. General anesthesia requires
airway management and frequently mechanical ventilation, both
of which can be extremely challenging in FOP patients (36, 37).
FOP patients often have jaw ankylosis, making conventional
direct laryngoscopy or even video-laryngoscopy impossible
for tracheal intubation. Moreover, even in the absence of a
temporomandibular joint (TMJ) ankylosis, direct laryngoscopy
is discouraged because hyperextension of the neck is limited–if
not impossible–due to fused cervical vertebrae and in addition,
overstretching of the TMJ joint or vertebral facet joints during
tracheal intubation might induce a temporomandibular joint
flare-up (5). Therefore, fiberoptic naso-tracheal intubation is
preferred in all FOP scheduled for general anesthesia (5). This
would have been possible in the current case, however, the risk
of general anesthesia was deemed unacceptably high. The patient
suffered from a severely restricted pulmonary function due to
a completely immobile thoracic cage (7, 9). It was anticipated
that high inspiratory airway pressures would be needed during
mechanical ventilation to maintain adequate gas exchange.
This can lead to over-distention of alveoli causing pulmonary
barotrauma (38). Other challenges that were anticipated were a
ventilation-perfusion mismatch and difficulties in weaning form
mechanical ventilation. In addition, FOP patients are known
to have impaired thoracic flexibility and weakened respiratory
muscles predisposing to ineffective coughing, with an increased

DISCUSSION
Although any kind of surgery is highly discouraged in
FOP patients due to an increased risk of flare-ups and
progression of the disease, this case demonstrates that in a lifethreatening situation–an operative procedure can be considered
and managed successfully even in severely affected patients.
It requires the assembly of a multidisciplinary FOP-dedicated
team with knowledge of the disease and preparations made in
anticipation of complications that may occur. In the current
case, the timely and detailed preparation on the multidisciplinary
team and the innovative techniques employed throughout the
perioperative period assured the benign outcome of the surgical
procedure. Because there is no effective treatment available to
stop the formation and progression of HO, surgical procedures
are highly discouraged as standard care of FOP (5, 29). Even
small traumata–e.g., biopsies—can cause sufficient damage to the
muscle and trigger a flare-up with subsequent HO formation
(30). In the described case, surgery was the only life-saving
option: it was judged that the patient was unlikely to survive
the rapidly increasing, progressive infections of her leg due to
antibiotic resistant organisms after many years of treatment.
Surprisingly, a negligible amount of HO formed after the
through-knee amputation, possibly due to a period of silent
disease activity before and at the time of the operation. The
reason for the quiescent disease in this patient is not known.
One hypothesis is that, as it is known that the immune system
plays a role in the pathogenesis of HO (31), the chronic
inflammation and antibiotic use could have suppressed disease
activity. Interestingly, 12 months after the surgical procedure
disease activity was noted at various sites with HO. This could
be the result of a normalized level of inflammation, or a systemic,
late effect of the surgical procedure itself. Based on case reports
in literature describing limb surgeries, where postoperatively
HO formation was observed in almost 90% of the cases (12–
21, 23–28), it was expected that clinically relevant HO would
form. It should be noted, that over 90% of the published
limb surgeries were performed to remove HO. Only in two
patients (7%) HO did not reoccur after the removal of HO.
Both patients received bisphosphonate treatment (19). Due to
the absence of the effect of bisphosphonate treatment in nine
others, it is more likely that the good result in those two can
be attributed either to an incomplete follow-up time or due to
limited imaging modalities as both cases are reported in 1976
(19). Removal of HO might be complex when it has formed
within a muscle or when it has fused with normal skeletal
bone. Removal of HO can therefore be considered as a high
impact procedure which triggers HO formation. In our case a
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risk of mucus retention and infection (5). Therefore, a regional
anesthesia approach was chosen, with ultrasound guidance to
identify structures and to limit tissue trauma. Glucocorticoids
were locally injected via the placed nerve block catheters in
an attempt to prevent a flare-up. Since regional anesthesia
alone was insufficient to ensure complete analgesia and patient’s
comfort, systemic drugs were added. As these drugs might
induce apnea, it is important to monitor the patient closely
and keep high-flow nasal oxygen standby in case support of
oxygenation is needed (39, 40). To conclude, based on the
literature it was almost certain that HO would form as a
response to a surgical procedure of a limb. In the current
case, HO was indeed formed, but even 12 months after surgery
the volume of the formed HO minimal. It is hypothesized
that the patient’s silent disease activity and the continuous
antibiotic treatments might have influenced this. If surgery needs
to be performed, it is important that it is performed by a
multidisciplinary team with knowledge about FOP and after
carefully weighing the surgical benefits against the challenges
and risks of both the anesthetic and surgical procedures for the
FOP patient.
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